Cible Skin investment from Verlinvest

French luxury skincare brand partners with Verlinvest to support its unique immuno-cosmetic product development and continued global expansion

Venture capital 2024, February

E-commerce & retail

“With this investment from Verlinvest, Cible Skin will be able to accelerate deployment in our two main markets, France and China, while evaluating potential for further expansion across Europe and America. Cible Skin stands out in the competitive skincare industry through the unrivalled satisfaction and advocacy from our customers. Our goal over the next five years is to become the market leader in luxury, science-backed, cosmetics and we believe Verlinvest is the perfect partner to help us on this path, with their track record of supporting strong international growth while preserving and strengthening the DNA of the brands they back.”

Jean Ginefri, President, and co-founder of Cible Skin

Cible Skin has announced a significant minority investment from Verlinvest, a global, consumer-focused, evergreen investment company. This new investment will enable the pioneering, science-backed skincare brand, Cible Skin, to accelerate growth across geographies including Europe, China and the United States, and supports the development of new products and treatments based on the company’s innovative patented immuno-cosmetic approach.

Cible Skin was founded in 2015 by Pharmaceutical Doctor, Raphaël Aknin, and fellow entrepreneur, Jean Ginefri, with the mission of creating a skincare brand that uses the science of cell immunity and rejuvenation to produce the most potent results. Cible Skin takes a rigorous, research-backed approach to developing high-quality formulations, made in France with the best natural, clean, active ingredients, and offers skincare products including cleansers, serums, and moisturizers. The brand also offers a range of exclusive treatments at its flagship clinic in Paris, La Maison Cible Skin, providing customers with both a luxurious experience and personalized, technical and scientific guidance through their skincare journey.

Cible Skin draws on the expertise of its Scientific Committee, chaired by Dr. Raphaël Aknin, which combines decades of experience in regenerative medicine and immunological science to preserve the health, equilibrium, and beauty of the skin through the innovation of immuno-cosmetics. This clinically proven method boosts the immune system of skin cells to protect, regenerate and repair the skin, with powerful anti-aging, anti-imperfect, antioxidant, and ultra-moisturizing results.